The study determined the risk of hospitalization or death was 87% lower in study participants who were given remdesivir than participants who received a placebo.
from WebMD Health webmd
Popular Posts
-
Stubborn Fat problems The Issue at Hand Many people, no matter their age or gender, face common problem of stubborn fat. Even with stric... -
The project will initially cover about 60,000 patients in remote locations. from healthcareitnews
-
The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquin...